Market Cap

Guangxi Liuzhou Pharmaceutical Co. Ltd Market Capitalization:

CN¥6.86 Billion

CNY as of July 1, 2025

US$957.0 Million

business Guangxi Liuzhou Pharmaceutical Co. Ltd Company Profile

Guangxi Liuzhou Pharmaceutical Co. Ltd Main Stock Listing

SSE: 603368

Market Capitalization History of Guangxi Liuzhou Pharmaceutical Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Distribution
Company Market Cap (USD)
McKesson Corporation $88.11 B
Cencora, Inc. $56.44 B
Cardinal Health, Inc. $38.66 B
Henry Schein, Inc. $9.31 B
Shanghai Pharmaceuticals Holding Co. Ltd $8.37 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Guangxi Liuzhou Pharmaceutical Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2025 CN¥7.43 B 5.79%
Jan. 1, 2024 CN¥7.03 B -4.10%
Jan. 1, 2023 CN¥7.33 B 21.85%
Jan. 1, 2022 CN¥6.01 B -18.94%
Jan. 1, 2021 CN¥7.42 B -17.89%
Jan. 1, 2020 CN¥9.04 B 34.58%
Jan. 1, 2019 CN¥6.71 B -22.32%
Jan. 1, 2018 CN¥8.64 B -19.66%
Jan. 1, 2017 CN¥10.76 B 11.61%
Jan. 1, 2016 CN¥9.64 B 34.63%
Jan. 1, 2015 CN¥7.16 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Guangxi Liuzhou Pharmaceutical Co. Ltd Categories

China languages Healthcare languages Medical Distribution
China Healthcare China Medical Distribution

Stocks & Indices

Guangxi Liuzhou Pharmaceutical Co. Ltd has the following listings and related stock indices.


Stock: SSE: 603368

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.